International Patent: COMPOSITIONS AND USE THEREOF IN TREATING HEPATITIS E INFECTIONS WITH BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-4'-FLUORO-N6-SUBSTITUTED-6-AMINO-2-SUBSTITUTED PURINE NUCLEOTIDES

GENEVA, July 18 -- ATEA PHARMACEUTICALS, INC. filed a patent application (US2026/010744) for “COMPOSITIONS AND USE THEREOF IN TREATING HEPATITIS E INFECTIONS WITH BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-4'-FLUORO-N6-SUBSTITUTED-6-AMINO-2-SUBSTITUTED PURINE NUCLEOTIDES”. With publication no. WO/2026/151964, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/7076

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....